Fusion Pharmaceuticals Inc. (FUSN) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 102 transactions totaling $57.4M, demonstrating a bullish sentiment with $54.0M in net insider flow. The most recent transaction on Jun 4, 2024 involved a transaction of 11,957 shares valued at $0.
No significant insider buying has been recorded for FUSN in the recent period.
No significant insider selling has been recorded for FUSN in the recent period.
Based on recent SEC filings, insider sentiment for FUSN is bullish with an Insider Alignment Score of 97/100 and a net flow of $54.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Fusion Pharmaceuticals Inc. (FUSN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading FUSN stock, having executed 102 transactions in the past 90 days. The most active insider is Chau Quang Khuong (Executive), who has made 4 transactions totaling $15.4M.
Get notified when executives and directors at FUSN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | P. Leamon Christopher | Executive | Disposition | 11,957 | $N/A | $0 | |
| Jun 4, 2024 | Burak Eric | Executive | Disposition | 38,490 | $N/A | $0 | |
| Jun 4, 2024 | J. Crowley John | Executive | Disposition | 10,410 | $N/A | $0 | |
| Jun 4, 2024 | Rawat Mohit | Executive | Disposition | 21,699 | $N/A | $0 | |
| Jun 4, 2024 | Valliant John | Executive | Disposition | 318,147 | $N/A | $0 | |
| Jun 4, 2024 | Gannon Steven | Executive | Disposition | 56,400 | $N/A | $0 | |
| Aug 31, 2023 | Rawat Mohit | Executive | Award | 12,843 | $N/A | $0 | |
| Aug 31, 2023 | P. Leamon Christopher | Executive | Award | 11,957 | $N/A | $0 | |
| Nov 11, 2022 | Quang Khuong Chau | Executive | Award | 42,093 | $2.38 | $100.2K | |
| Aug 11, 2022 | Gannon Steven | Executive | Purchase | 44,400 | $2.03 | $90.1K | |
| Apr 27, 2022 | Valliant John | Executive | Sale | 4,511 | $6.03 | $27.2K | |
| Apr 26, 2022 | Valliant John | Executive | Sale | 2,147 | $6.07 | $13.0K | |
| Apr 25, 2022 | Valliant John | Executive | Sale | 2,036 | $6.03 | $12.3K | |
| Apr 21, 2022 | Valliant John | Executive | Sale | 922 | $6.01 | $5.5K | |
| Apr 20, 2022 | Valliant John | Executive | Sale | 367 | $6.02 | $2.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 16 | $55.7M | 96.9% |
Sale(S) | 55 | $1.7M | 3.0% |
Award(A) | 5 | $100.2K | 0.2% |
Disposition(D) | 6 | $0 | 0.0% |
Conversion(C) | 20 | $0 | 0.0% |
Insiders at Fusion Pharmaceuticals Inc. are accumulating shares at an accelerated pace. With 16 insiders making 102 transactions totaling $55.7M in purchases versus $1.7M in sales, the net buying activity of $54.0M signals strong executive confidence. Chau Quang Khuong (Executive) leads the buying activity with $15.4M in transactions across all time.